|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,146.50 GBX | -0.99% |
|
+2.69% | +17.07% |
| 05:46pm | Bernstein Upbeat on GSK Amid Upcoming Catalysts; Price Target, Forecasts Revised | MT |
| 04:37am | FDA refuses to review Moderna's influenza vaccine application | RE |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 12TCr | AA | ||||||||
| 92TCr | A | ||||||||
| 57TCr | BBB | ||||||||
| 39TCr | AA | ||||||||
| 37TCr | AA | ||||||||
| 30TCr | AAA | ||||||||
| 30TCr | A | ||||||||
| 29TCr | A | ||||||||
| 22TCr | A | ||||||||
| 20TCr | A | ||||||||
| 18TCr | AAA | ||||||||
| 16TCr | BBB | ||||||||
| 12TCr | A | ||||||||
| 12TCr | AA | ||||||||
| 12TCr | A | ||||||||
| 9.63TCr | AA | ||||||||
| 6.37TCr | - | - | - | - | - | - | - | ||
| 5.72TCr | AA | ||||||||
| 5.61TCr | AA | ||||||||
| 5.4TCr | AA | ||||||||
| Average | 23.54TCr | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















